DECIPHERA PHARMACEUTICALS IN's ticker is and the CUSIP is 24344T901. A total of 5 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $280,000 | -11.9% | 30,200 | -7.1% | 0.00% | – |
| Q4 2021 | $318,000 | -65.2% | 32,500 | +30.0% | 0.00% | – |
| Q2 2021 | $915,000 | -53.8% | 25,000 | -37.5% | 0.00% | – |
| Q3 2020 | $1,982,000 | -17.0% | 40,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,389,000 | -91.5% | 40,000 | -91.1% | 0.00% | -100.0% |
| Q4 2019 | $28,008,000 | – | 450,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 99,700 | $3,650,000 | 0.11% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,900 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,200 | $373,000 | 0.00% |
| JPMORGAN CHASE & CO | 25,000 | $915,000 | 0.00% |